SCA 12
OFF PUMP MYOCARDIAL REVASCULARIZATION AND TRANSFUSION PRACTICES IN CARDIAC SURGERY
Jose GB¹, Karski JM¹, Fedorko L¹, Chamchad D¹, Mukherji J¹, Cusimano RJ², Varadarjan B¹, Djaiani GN¹
Department of Anesthesia & Pain Management¹ and Division of Cardiac Surgery², Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada

SCA 13
ASSOCIATION OF THROMBOELASTOGRAPHY (MA) AND THROMBOTIC COMPLICATIONS AFTER MAJOR NON-CARDIAC SURGERY
McCrath DJ, Cerboni E, Hirsh A, Frumento RJ, Bennett-Guerrero E
Columbia University, New York, NY

SCA 14
OFF-PUMP CORONARY ARTERY BYPASS GRAFTING SURGERY PRESERVES PLATELET GLYCOPROTEIN IB EXPRESSION BUT DOES NOT PREVENT PLATELET ACTIVATION
Greilich PE¹, Brouse CF¹, Rinder CS², Douning LK¹, Jessen ME³
Departments of Anesthesiology & Pain Management¹ and Cardiovascular and Thoracic Surgery³, University of Texas Southwestern - Dallas Veterans Affairs Medical Centers, Dallas, Texas; Departments of Anesthesiology and Laboratory Medicine, Yale University, New Haven, CT²

SCA 15
IN VITRO EFFECTS OF DX-88, A NOVEL INHIBITOR OF KALLIKREIN AND CONTACT ACTIVATION
Tanaka KA, Sato N, Szlam F, Katori N, Levy JH
Anesthesiology, Emory University, Atlanta, GA

SCA 16
EVALUATING THE TRANSFUSION EFFECTS ON OUTCOME FOR PATIENTS UNDERGOING PRIMARY CORONARY ARTERY BYPASS GRAFTING
Green JA¹, Spiess BD¹, Reynolds PS¹, Higgins R², Makhoul K¹, Levin J¹, Sutherland M¹, Aron T², McCarthy H², DeAnda A², Kasirajan V²
Departments of Anesthesiology¹ and Cardiothoracic Surgery², Virginia Commonwealth University/Medical College of Virginia Hospitals, Richmond, VA

SCA 17
POTENTIAL FINANCIAL SAVINGS OF A "BLOODLESS" CARDIAC SURGERY INITIATIVE
Green JA¹, Reynolds PS¹, Makhoul K¹, Levin J¹, Higgins R², DeAnda A², McCarthy H², Falcucci O¹, Slaughter TF¹, Roseff SD³, Spiess BD¹
Departments of Anesthesiology¹, Surgery² and Pathology³, Virginia Commonwealth University/Medical College of Virginia, Richmond, VA

SCA 18
EPSILON-AMINOCAPROIC ACID ADMINISTRATION IN OFF-PUMP CORONARY ARTERY BYPASS GRAFT SURGERY: RESULTS OF A RANDOMIZED BLINDED CLINICAL TRIAL
Jalbout M, Anca D, Mehta N, Frumento R, Bennett-Guerrero E
Anesthesiology, Columbia University, New York, New York

SCA 19
PREDICTORS OF TRANSFUSION REQUIREMENTS FOR MAJOR CARDIAC SURGICAL PROCEDURES IN A PROGRAM DEDICATED TO BLOOD CONSERVATION
Moskowitz DM¹, Goldweit RS¹, Cousineau KM¹, Klein JJ¹, Bodian C², Perelman SI¹, Mitchel MB¹, Mahajan S¹, Shander A¹, Rothman H¹, Ergin MA¹
Englewood Hospital and Medical Center, Englewood, NJ¹ and Mount Sinai Medical Center, New York, NY²

SCA 20
DOSE FINDING TO MAINTAIN PHYSIOLOGIC ANTITHROMBIN ACTIVITY DURING AND AFTER CABG
Busley R¹, Dietrich W¹, Braun S², Weipert J³, Richter J¹
Departments of Anesthesiology¹, Laboratory Medicine² and Cardiac Surgery³, German Heart Center Munich, Munich, Germany

SCA 21
ANTI-ENDOTOXIN CORE ANTIBODIES (ENDOCAB) DO NOT INFLUENCE THE INFLAMMATORY RESPONSE TO CARDIOPULMONARY BYPASS
Kent BA, Mathew JP, Phillips-Bute BG, Newman MF, Marica LS, Grocott HP
Anesthesiology, Duke University, Durham, North Carolina

SCA 22
TRANEXAMIC ACID AND EARLY GRAFT PATENCY AFTER CORONARY ARTERY BYPASS GRAFT SURGERY.
Karski, J
Department of Anesthesia, Toronto, Ontario, Canada

SCA 23
WITHDRAWN